Works by Xu, Jianming


Results: 384
    1
    2
    3
    4
    5
    6
    7

    Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703).

    Published in:
    Oncologist, 2021, v. 26, n. 10, p. e1693, doi. 10.1002/onco.13857
    By:
    • Chi, Yihebali;
    • Shu, Yongqian;
    • Ba, Yi;
    • Bai, Yuxian;
    • Qin, Baoli;
    • Wang, Xiuwen;
    • Xiong, Jianping;
    • Xu, Nong;
    • Zhang, Helong;
    • Zhou, Jianfeng;
    • Xu, Jianming;
    • Cheng, Ying;
    • Feng, Jifeng;
    • Hu, Chunhong;
    • Chen, Yigui;
    • Chen, Zhendong;
    • Wang, Jufeng;
    • Dang, Chengxue;
    • Wang, Jianhong;
    • Wan, Yiye
    Publication type:
    Article
    8

    Long-term follow-up of Helicobacter pylori reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study.

    Published in:
    Emerging Microbes & Infections, 2020, v. 9, n. 1, p. 548, doi. 10.1080/22221751.2020.1737579
    By:
    • Xie, Yong;
    • Song, Conghua;
    • Cheng, Hong;
    • Xu, Canxia;
    • Zhang, Zhenyu;
    • Wang, Jiangbin;
    • Huo, Lijuan;
    • Du, Qin;
    • Xu, Jianming;
    • Chen, Ye;
    • Zhang, Xiaomei;
    • Zhang, Guoxin;
    • Yang, Guibin;
    • Zuo, Xiuli;
    • Guo, Tao;
    • Lu, Yapi;
    • Wang, Fen;
    • Wang, Xuehong;
    • Zhuang, Kun;
    • Chen, Shiyao
    Publication type:
    Article
    9

    Long-term follow-up of Helicobacter pylori reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study.

    Published in:
    Emerging Microbes & Infections, 2020, v. 9, n. 1, p. 548, doi. 10.1080/22221751.2020.1737579
    By:
    • Yong Xie;
    • Conghua Song;
    • Hong Cheng;
    • Canxia Xu;
    • Zhenyu Zhang;
    • Jiangbin Wang;
    • Lijuan Huo;
    • Qin Du;
    • Jianming Xu;
    • Ye Chen;
    • Xiaomei Zhang;
    • Guoxin Zhang;
    • Guibin Yang;
    • Xiuli Zuo;
    • Tao Guo;
    • Yapi Lu;
    • Fen Wang;
    • Xuehong Wang;
    • Kun Zhuang;
    • Shiyao Chen
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial.

    Published in:
    Advances in Therapy, 2020, v. 37, n. 11, p. 4585, doi. 10.1007/s12325-020-01477-w
    By:
    • Li, Jin;
    • Guo, Weijian;
    • Bai, Yuxian;
    • Deng, Yanhong;
    • Yang, Lei;
    • Chen, Zhendong;
    • Zhong, Haijun;
    • Xu, Ruihua;
    • Pan, Hongming;
    • Shu, Yongqian;
    • Yuan, Ying;
    • Zhou, Jianfeng;
    • Xu, Nong;
    • Liu, Tianshu;
    • Ma, Dong;
    • Wu, Changping;
    • Cheng, Ying;
    • Xu, Jianming;
    • Chen, Donghui;
    • Li, Wei
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50